Morgan Stanley Maintains Equal-Weight on Altria Group, Raises Price Target to $51
Morgan Stanley analyst Pamela Kaufman maintains Altria Group (NYSE:MO) with a Equal-Weight and raises the price target from $47 to $51.
(MO) – Analyzing Altria Group Inc’s Short Interest
Altria Group Inc's (NYSE:MO) short percent of float has fallen 6.56% since last its last report. The company recently reported that it has 10.47 million shares sold short, which is 0.57% of all regular shares that are available for trading.
B of A Securities Downgrades Altria Group to Neutral, Lowers Price Target to $50
B of A Securities analyst Lisa Lewandowski downgrades Altria Group (NYSE:MO) from Buy to Neutral and lowers the price target from $56 to $50.
Corporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table
This article was originally published on The Bluntness, and appears here with permission.
As more big business movers and shakers appear to be ratcheting up their incursions into the cannabis industry, industry advocates are stepping up their defense.
Cronos Stock Continues To Dive After Earnings Report Delay, BofA Lowers Price Target
Cannabis company Cronos Group Inc.
Ominous Death Cross Forms On Altria Group’s Chart
If history is any guide, there may be trouble ahead for shares of Altria Group (NYSE:MO). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
What Are Whales Doing With Altria Group
A whale with a lot of money to spend (and possibly insider knowledge) has taken a noticeably bearish stance on Altria Group.
Looking at options history for Altria Group (NYSE:MO) we detected 12 strange trades.
Morgan Stanley Downgrades Altria Group to Equal-Weight, Lowers Price Target to $47
Morgan Stanley analyst Pamela Kaufman downgrades Altria Group (NYSE:MO) from Overweight to Equal-Weight and lowers the price target from $52 to $47.